Misoprostol

This classification denotes a prostaglandin analogue and cytoprotective agent and anti-ulcer agent with the molecular formula C22H38O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0E43V0BB57, chemically known as prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13e)-(+-)- but generally known as misoprostol, which bears US NIH Compound Identifier 5282381. European Medicines Agency schedules Misoprostol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08998MIG. The term MISOPROSTOL is an International Non-Proprietary Name. World Health Organization schedules misoprostol in its Anatomical Therapeutic Chemical (ATC) Classification. MISOPROSTOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule misoprostol under HS 29375000 and SITC 54156. As of Q4 2014, MISOPROSTOL remains the US FDA Preferred Term for this commodity. Misoprostol bears US NLM identifiers UMLS ID C0085174 and NCI Concept Code C1313. SMILES: OC1C(C(CCCCCCC(=O)OC)C(=O)C1)/C=C/CC(O)(CCCC)C.